GlassScriptPhysician profile
Luke Mugge
NPI 1518521822
$5,637.76
in general payments reported to CMS, 2019-2025
8 companies · $714 in 2025
The $714 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.17 · 2022: $812 · 2023: $170 · 2024: $3,927 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,518 · Travel and Lodging: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,517.75 |
| Travel and Lodging | $1,292.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,619.93 | 2022-2024 | Everest Spinal System, Vitoss, Mesa Spinal System |
| Si-Bone, INC. | $1,261.44 | 2023-2025 | |
| Globus Medical, INC. | $341.36 | 2024 | Quartex |
| Depuy Synthes Sales INC. | $182.13 | 2025 | Vivigen Mis Delivery System, Teligen, Trialtis |
| Bioventus LLC | $148.30 | 2024 | Bonescalpel & Sonicone (O.R.), Nexus-10 Mkii |
| Nuvasive, INC. | $41.50 | 2023 | Xlif |
| Ethicon US, LLC | $27.93 | 2025 | Stratafix, Evarrest, Surgicel Nu-Knit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Mugge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.